Table: Fuji Pharmaceutical - 9-MTH group results

Fuji Pharma

06/08/2020 08:30

Aug 6 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Jun 30, 2020        Jun 30, 2019     Sep 30, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             24.90               27.32            33.83    
                 (-8.9 pct)          (-2.0 pct)       (-6.8 pct)  
  Operating          2.22                3.73             2.57    
                 (-40.3 pct)         (+5.0 pct)       (-38.4 pct) 
  Recurring          2.15                3.71             2.50    
                 (-42.1 pct)         (+4.4 pct)       (-40.0 pct) 
  Net                1.57                2.52             1.66    
                 (-37.9 pct)         (-3.3 pct)       (-43.8 pct) 
  EPS             50.24 yen           83.17 yen        53.44 yen  
  Ann Div                             29.00 yen        29.00 yen  
  -Q2 div         14.00 yen           14.00 yen                   
  -Q4 div                             15.00 yen        15.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T